In the news

Oklahoma’s 1980s Oil Problems Leads to Career in Biotechnology for Local Lawyer

April 26, 2016 – Excerpt from NewsOk: “Through an association with William Hagstrom of Alpha Bio Partners, Branch became acquainted with OU professor Anne Pereira, Ph.D. Pereira had co-founded Biolytx Pharmaceuticals with Hagstrom based on her groundbreaking work in developing peptides that kill antibiotic resistant bacteria.” Read full article – http://newsok.com/article/5494114

Read More

Heloise Anne Pereira named 2016 National Academy of Inventors Fellow

December 16, 2015 – Excerpt from OCRID: University of Oklahoma Health Sciences Center Professor Heloise Anne Pereira has been named a 2016 National Academy of Inventors Fellow, a high professional distinction awarded to academic inventors who have demonstrated a prolific spirit of innovation in creating or facilitating outstanding inventions that have made a tangible impact…

Read More

Biolytx funds raised

November 7, 2015 – Excerpt from NewsOK: A $500,000 investment from the i2E Inc.-managed Oklahoma Seed Capital Fund recently led a $1.1 million financing round in Oklahoma City-based Biolytx Pharmaceuticals Corp. Biolytx is developing a drug designed to promote wound healing and kill antibiotic resistant bacteria. This latest financing also included $200,000 from i2E-managed SeedStep…

Read More

OU Grad Dean Targets Drug Resistant Bacteria

December 8, 2014 – Excerpt from i2e: Just a few years ago, we lived in a world that wasn’t connected by wireless networks and instantaneous communication. So you might have felt a bit isolated if you were raised in, say, Australia. That was definitely the perception of Anne Pereira in the early 1980s as she…

Read More